Assessment of outcomes of elective cancer surgeries in children during coronavirus disease 2019 pandemic

Abstract

Abstract To describe the outcomes of elective cancer surgeries and adverse consequences on the patients and medical staff due to the surgical interventions in children during the Coronavirus Disease 2019 (COVID-19) pandemic. The study included children younger than 15\u200ayears who underwent elective cancer surgeries from March 4, 2020 and December 3, 2020. A total of 121 patients (62% male; median age, 3\u200ayears) underwent surgery. The surgical procedures included nephrectomies (n\u200a=\u200a18), neuroblastoma (n\u200a=\u200a26) and soft tissue tumor resections (n\u200a=\u200a24) and complex surgical procedures like extended liver resections (n\u200a=\u200a2), intra-atrial thrombectomy under cardiopulmonary bypass (n\u200a=\u200a2), pancreatoduodenectomy (n\u200a=\u200a1), and free microvascular flaps (n\u200a=\u200a7). Clavien-Dindo Grade III complications were 5% (n\u200a=\u200a6), and there were no postoperative deaths. Preoperative COVID-19 testing was performed in 82% of children, and only 2% showed severe acute respiratory syndrome coronavirus 2 positivity. Postoperatively, 26 children were tested because of specific symptoms and, 6 tested positive for severe acute respiratory syndrome coronavirus 2. Except for a median delay of 23\u200adays in treatment, none of the patients with COVID-19 required critical hospital management. None of the surgical residents or faculty acquired COVID-19, while 4 each medical and support staff were tested positive in the study period. COVID-19 was not a deterrent for continued cancer care, and surgeries could be safely performed adopting universal preventive measures without any added morbidity from COVID-19. Caregivers and centers dealing with childhood cancers can be encouraged to sustain or seek early healthcare.